Business
NOLA_B: Strong margin gains and stable sales, led by Medical, with robust outlook and expansion plans
NOLA_B: Strong margin gains and stable sales, led by Medical, with robust outlook and expansion plans
About this update from Nolato Ab Class B
Q1 2025 saw flat sales but strong margin gains, with EBITDA up 14% and Medical Solutions leading improvements. Engineered Solutions faced lower automotive sales but offset with materials growth and cost actions. Margin gains are expected to be sustainable, with further improvements targeted, and investments support future expansion.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.